Morgan Stanley Maintains Overweight on Lam Research, Lowers Price Target to $339

Benzinga · 1d ago
Morgan Stanley analyst Shane Brett maintains Lam Research (NASDAQ:LRCX) with a Overweight and lowers the price target from $385 to $339.